Frontier Biotechnologies Inc. Class ASSE: 688221

Announcement on Voluntary Disclosure of Adding API Supplier for Albuvirtide for Injection and Subsidiary Sichuan Frontier Biopharmaceutical Co., Ltd. Passing Drug GMP Compliance Inspection

· Issued by Frontier Biotechnologies Inc. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Adding API Supplier for Albuvirtide for Injection and Subsidiary Sichuan Frontier Biopharmaceutical Co., Ltd. Passing Drug GMP Compliance Inspection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis